Copyright Reports & Markets. All rights reserved.

Global Nanotechnology-based Drug Delivery Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Nanotechnology-based Drug Delivery by Type
    • 1.3.1 Overview: Global Nanotechnology-based Drug Delivery Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Nanotechnology-based Drug Delivery Consumption Value Market Share by Type in 2025
    • 1.3.3 Nanocrystals
    • 1.3.4 Nanoparticles
    • 1.3.5 Liposomes
    • 1.3.6 Micelles
    • 1.3.7 Others
  • 1.4 Global Nanotechnology-based Drug Delivery Market by Application
    • 1.4.1 Overview: Global Nanotechnology-based Drug Delivery Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Research Institute
    • 1.4.4 Others
  • 1.5 Global Nanotechnology-based Drug Delivery Market Size & Forecast
  • 1.6 Global Nanotechnology-based Drug Delivery Market Size and Forecast by Region
    • 1.6.1 Global Nanotechnology-based Drug Delivery Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Nanotechnology-based Drug Delivery Market Size by Region, (2021-2032)
    • 1.6.3 North America Nanotechnology-based Drug Delivery Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Nanotechnology-based Drug Delivery Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Nanotechnology-based Drug Delivery Market Size and Prospect (2021-2032)
    • 1.6.6 South America Nanotechnology-based Drug Delivery Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Nanotechnology-based Drug Delivery Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 AbbVie Inc.
    • 2.1.1 AbbVie Inc. Details
    • 2.1.2 AbbVie Inc. Major Business
    • 2.1.3 AbbVie Inc. Nanotechnology-based Drug Delivery Product and Solutions
    • 2.1.4 AbbVie Inc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 AbbVie Inc. Recent Developments and Future Plans
  • 2.2 BlueWillow Biologics Inc.
    • 2.2.1 BlueWillow Biologics Inc. Details
    • 2.2.2 BlueWillow Biologics Inc. Major Business
    • 2.2.3 BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Product and Solutions
    • 2.2.4 BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 BlueWillow Biologics Inc. Recent Developments and Future Plans
  • 2.3 Camurus AB
    • 2.3.1 Camurus AB Details
    • 2.3.2 Camurus AB Major Business
    • 2.3.3 Camurus AB Nanotechnology-based Drug Delivery Product and Solutions
    • 2.3.4 Camurus AB Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Camurus AB Recent Developments and Future Plans
  • 2.4 Celgene, lnc.
    • 2.4.1 Celgene, lnc. Details
    • 2.4.2 Celgene, lnc. Major Business
    • 2.4.3 Celgene, lnc. Nanotechnology-based Drug Delivery Product and Solutions
    • 2.4.4 Celgene, lnc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Celgene, lnc. Recent Developments and Future Plans
  • 2.5 Cristal Therapeutics
    • 2.5.1 Cristal Therapeutics Details
    • 2.5.2 Cristal Therapeutics Major Business
    • 2.5.3 Cristal Therapeutics Nanotechnology-based Drug Delivery Product and Solutions
    • 2.5.4 Cristal Therapeutics Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Cristal Therapeutics Recent Developments and Future Plans
  • 2.6 EyePoint Pharmaceuticals
    • 2.6.1 EyePoint Pharmaceuticals Details
    • 2.6.2 EyePoint Pharmaceuticals Major Business
    • 2.6.3 EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Product and Solutions
    • 2.6.4 EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 EyePoint Pharmaceuticals Recent Developments and Future Plans
  • 2.7 Johnson and Johnson
    • 2.7.1 Johnson and Johnson Details
    • 2.7.2 Johnson and Johnson Major Business
    • 2.7.3 Johnson and Johnson Nanotechnology-based Drug Delivery Product and Solutions
    • 2.7.4 Johnson and Johnson Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Johnson and Johnson Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Nanotechnology-based Drug Delivery Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Nanotechnology-based Drug Delivery by Company Revenue
    • 3.2.2 Top 3 Nanotechnology-based Drug Delivery Players Market Share in 2025
    • 3.2.3 Top 6 Nanotechnology-based Drug Delivery Players Market Share in 2025
  • 3.3 Nanotechnology-based Drug Delivery Market: Overall Company Footprint Analysis
    • 3.3.1 Nanotechnology-based Drug Delivery Market: Region Footprint
    • 3.3.2 Nanotechnology-based Drug Delivery Market: Company Product Type Footprint
    • 3.3.3 Nanotechnology-based Drug Delivery Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Nanotechnology-based Drug Delivery Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Nanotechnology-based Drug Delivery Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Nanotechnology-based Drug Delivery Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Nanotechnology-based Drug Delivery Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Nanotechnology-based Drug Delivery Consumption Value by Type (2021-2032)
  • 6.2 North America Nanotechnology-based Drug Delivery Market Size by Application (2021-2032)
  • 6.3 North America Nanotechnology-based Drug Delivery Market Size by Country
    • 6.3.1 North America Nanotechnology-based Drug Delivery Consumption Value by Country (2021-2032)
    • 6.3.2 United States Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Nanotechnology-based Drug Delivery Consumption Value by Type (2021-2032)
  • 7.2 Europe Nanotechnology-based Drug Delivery Consumption Value by Application (2021-2032)
  • 7.3 Europe Nanotechnology-based Drug Delivery Market Size by Country
    • 7.3.1 Europe Nanotechnology-based Drug Delivery Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)
    • 7.3.3 France Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Nanotechnology-based Drug Delivery Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Nanotechnology-based Drug Delivery Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Nanotechnology-based Drug Delivery Market Size by Region
    • 8.3.1 Asia-Pacific Nanotechnology-based Drug Delivery Consumption Value by Region (2021-2032)
    • 8.3.2 China Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)
    • 8.3.5 India Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Nanotechnology-based Drug Delivery Consumption Value by Type (2021-2032)
  • 9.2 South America Nanotechnology-based Drug Delivery Consumption Value by Application (2021-2032)
  • 9.3 South America Nanotechnology-based Drug Delivery Market Size by Country
    • 9.3.1 South America Nanotechnology-based Drug Delivery Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Nanotechnology-based Drug Delivery Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Nanotechnology-based Drug Delivery Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Country
    • 10.3.1 Middle East & Africa Nanotechnology-based Drug Delivery Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Nanotechnology-based Drug Delivery Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Nanotechnology-based Drug Delivery Market Drivers
  • 11.2 Nanotechnology-based Drug Delivery Market Restraints
  • 11.3 Nanotechnology-based Drug Delivery Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Nanotechnology-based Drug Delivery Industry Chain
  • 12.2 Nanotechnology-based Drug Delivery Upstream Analysis
  • 12.3 Nanotechnology-based Drug Delivery Midstream Analysis
  • 12.4 Nanotechnology-based Drug Delivery Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Nanotechnology-based Drug Delivery market size was valued at US$ 127330 million in 2025 and is forecast to a readjusted size of US$ 274300 million by 2032 with a CAGR of 11.7% during review period.
    This report is a detailed and comprehensive analysis for global Nanotechnology-based Drug Delivery market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Nanotechnology-based Drug Delivery market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Nanotechnology-based Drug Delivery market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Nanotechnology-based Drug Delivery market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Nanotechnology-based Drug Delivery market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Nanotechnology-based Drug Delivery
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Nanotechnology-based Drug Delivery market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie Inc., BlueWillow Biologics Inc., Camurus AB, Celgene, lnc., Cristal Therapeutics, EyePoint Pharmaceuticals, Johnson and Johnson, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Nanotechnology-based Drug Delivery market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Nanocrystals
    Nanoparticles
    Liposomes
    Micelles
    Others
    Market segment by Application
    Hospital
    Research Institute
    Others
    Market segment by players, this report covers
    AbbVie Inc.
    BlueWillow Biologics Inc.
    Camurus AB
    Celgene, lnc.
    Cristal Therapeutics
    EyePoint Pharmaceuticals
    Johnson and Johnson
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Nanotechnology-based Drug Delivery product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Nanotechnology-based Drug Delivery, with revenue, gross margin, and global market share of Nanotechnology-based Drug Delivery from 2021 to 2026.
    Chapter 3, the Nanotechnology-based Drug Delivery competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Nanotechnology-based Drug Delivery market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Nanotechnology-based Drug Delivery.
    Chapter 13, to describe Nanotechnology-based Drug Delivery research findings and conclusion.

    Buy now